Literature DB >> 16199267

Natural course of intraocular pressure after cataract surgery with sodium chondroitin sulfate 4%-sodium hyaluronate 3% (Viscoat).

Georg Rainer1, Rupert Menapace, Katharina Emanuela Schmid, Stefan Sacu, Barbara Kiss, Georg Heinze, Oliver Findl.   

Abstract

PURPOSE: To investigate the natural course of intraocular pressure (IOP) and its peak after small-incision cataract surgery with chondroitin sulfate 4%-sodium hyaluronate 3% (Viscoat, Alcon Laboratories, Inc., Fort Worth, TX).
DESIGN: Observational case series. PARTICIPANTS: This prospective study comprised 40 eyes of 40 consecutive cataract patients scheduled for small-incision cataract surgery.
METHODS: Cataract surgery was performed with sodium chondroitin sulfate 4%-sodium hyaluronate 3% as the ophthalmic viscosurgical device, which was removed as completely as possible from the eye at the end of surgery. The IOP was measured preoperatively and 30 minutes; 1, 2, 3, 4, 6, 8, and 20 to 24 hours; and 1 week postoperatively. MAIN OUTCOME MEASURES: Postoperative IOP increase.
RESULTS: The mean IOP increased significantly at all observation times during the first 20 to 24 hours, with a peak increase of 13.4+/-9.4 mmHg after 1 hour (P<0.05). In all, 28 eyes (70%) had an IOP spike to 30 mmHg or higher. Sixty-eight percent of these spikes occurred at 30 minutes as well as at 1 hour and 2 hours postoperatively. At 20 to 24 hours, no eye had an IOP spike to 30 mmHg or higher.
CONCLUSIONS: Significant IOP increases were found during the first 24 hours, peaking at 1 hour after surgery. With a single postoperative IOP measurement, between 30 minutes and 2 hours after surgery, two thirds of these IOP spikes could be detected. To detect all IOP spikes, a second measurement between 4 and 6 hours after surgery would be necessary.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199267     DOI: 10.1016/j.ophtha.2005.05.011

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  A class I (Senofilcon A) soft contact lens prevents UVB-induced ocular effects, including cataract, in the rabbit in vivo.

Authors:  Frank J Giblin; Li-Ren Lin; Victor R Leverenz; Loan Dang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

2.  Rat chronic glaucoma model induced by intracameral injection of microbeads suspended in sodium sulfate-sodium hyaluronate.

Authors:  Yoshiko Matsumoto; Akiyasu Kanamori; Makoto Nakamura; Akira Negi
Journal:  Jpn J Ophthalmol       Date:  2014-03-11       Impact factor: 2.447

Review 3.  Impact of Ophthalmic Viscosurgical Devices in Cataract Surgery.

Authors:  Monali S Malvankar-Mehta; Angel Fu; Yasoda Subramanian; Cindy Hutnik
Journal:  J Ophthalmol       Date:  2020-10-20       Impact factor: 1.909

4.  A clinical comparison between DisCoVisc and 2% hydroxypropylmethylcellulose in phacoemulsification: a fellow eye study.

Authors:  Rodrigo F Espíndola; Emerson F S Castro; Marcony R Santhiago; Newton Kara-Junior
Journal:  Clinics (Sao Paulo)       Date:  2012-09       Impact factor: 2.365

5.  Safety, efficacy, and intraoperative characteristics of DisCoVisc and Healon ophthalmic viscosurgical devices for cataract surgery.

Authors:  Satish S Modi; James A Davison; Tom Walters
Journal:  Clin Ophthalmol       Date:  2011-09-23

6.  Use of viscoelastic substance in ophthalmic surgery - focus on sodium hyaluronate.

Authors:  Tomomi Higashide; Kazuhisa Sugiyama
Journal:  Clin Ophthalmol       Date:  2008-03

7.  Safety and effectiveness of a new ophthalmic viscosurgical device: randomized, controlled study.

Authors:  Mark Packer; John P Berdahl; Damien F Goldberg; Lester Hosten; George Lau
Journal:  J Cataract Refract Surg       Date:  2022-02-08       Impact factor: 3.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.